Xcopri (cenobamate)

Pharma

SK settles with MSN over generic of seizure med Xcopri: reports

SK has struck a settlement with generics manufacturer MSN, which will allow the Korean company to extend its market exclusivity beyond 2032 for Xcopri.

Kevin Dunleavy Aug 19, 2026 11:21am

SK eyes Xcopri expansion with phase 3 win in new seizure type

Sep 17, 2025 11:32am

A frame from SK Life Sciences Road to Reduction ad for Xcopri showing a car driving down a straight road under the drugs

SK starts ad campaign to drive patients to seizure drug Xcopri

May 20, 2025 10:59am